Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Volckmann

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|January 27, 2022
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With NeuroblastomaIedan R N Verly, Yvette A H Matser, René Leen, et al.
Nature Immunology|November 15, 2019
Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologiesJochem H Bernink, Yoichiro Ohne, Marcel B M Teunissen, et al.
Nature Immunology|July 3, 2019
c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologiesJochem H Bernink, Yoichiro Ohne, Marcel B M Teunissen, et al.
British Journal of Cancer|March 17, 2022
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by <sup>68</sup>Ga-FAPI-PET imagingEsther Strating, Emma Wassenaar, Mathijs Verhagen, et al.
Nature Communications|April 6, 2019
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastomaTim van Groningen, Nurdan Akogul, Ellen M Westerhout, et al.
The EMBO Journal|June 14, 2012
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersJavier Muñoz, Daniel E Stange, Arnout G Schepers, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Clinical Epigenetics|June 16, 2025
Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancerSarah Arroyo Villora, Yufen Zhao, Paula Castellanos Silva, et al.
Cancer Research|July 18, 2022
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|January 27, 2022
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With NeuroblastomaIedan R N Verly, Yvette A H Matser, René Leen, et al.
Nature Immunology|November 15, 2019
Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologiesJochem H Bernink, Yoichiro Ohne, Marcel B M Teunissen, et al.
Nature Immunology|July 3, 2019
c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologiesJochem H Bernink, Yoichiro Ohne, Marcel B M Teunissen, et al.
British Journal of Cancer|March 17, 2022
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by <sup>68</sup>Ga-FAPI-PET imagingEsther Strating, Emma Wassenaar, Mathijs Verhagen, et al.
Nature Communications|April 6, 2019
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastomaTim van Groningen, Nurdan Akogul, Ellen M Westerhout, et al.
The EMBO Journal|June 14, 2012
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersJavier Muñoz, Daniel E Stange, Arnout G Schepers, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Clinical Epigenetics|June 16, 2025
Epigenetic silencing and CRISPR-mediated reactivation of tight junction protein claudin10b (CLDN10B) in renal cancerSarah Arroyo Villora, Yufen Zhao, Paula Castellanos Silva, et al.
Cancer Research|July 18, 2022
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Pageof 4